Assessing the Effect of an Antioxidant-Rich Diet on Metabolic Syndrome Risk Using the Dietary Antioxidant Index
Recruiting
N/A
Interventional Study
Metabolic Syndrome Risk Factors
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 45
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 55 (estimated)
- Sponsor
- University of Veterinary and Animal Sciences, Lahore - Pakistan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Metabolic syndrome (MetS) is a cluster of metabolic disorders characterized by elevated levels of blood glucose, hypertension, dyslipidemia, and abdominal obesity. Globally, it is a major public health concern. International studies have linked higher Dietary Antioxidant Index with reduced risk of MetS, as antioxidants play a role in lowering the risk of MetS by reducing oxidative stress, a key co…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18-45 years
* Metabolic syndrome risk (abdominal obesity \& elevated BP as per NCEP ATP III criteria).
* Low fruit \& veg intake (\<5 serv./day) as per WHO.
* Willing to follow an intervention
* Non-pregnant or lactating
* Not diagnosed with malabsorption syndrome …
Contacts